SENNA PLUS

Manufacturer
Direct_Rx
Effective date
2019-07-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:17:46

Label at a glance#

ProductSENNA PLUS
Active ingredientSENNOSIDES, DOCUSATE SODIUM
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION


Docusate Sodium 50 mg
Sennosides 8.6 mg

OTC - PURPOSE SECTION

Stool softener

Laxative

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

this product generally produces a bowel movement in 6 to 12 hours

WARNINGS SECTION

Do not use for more than 1 week unless directed by a doctor

Ask a doctor before use if you

have abdominal pain, nausea or vomiting
are taking mineral oil
have noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if you have

no bowel movement within 12 hours
rectal bleeding
these could signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

OTHER SAFETY INFORMATION

each tablet contains: calcium 20 mg, sodium 6 mg
Tamper Evident: Do not use if imprinted seal under cap is missing or broken.
store at room temperature

INACTIVE INGREDIENT SECTION


cellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6, hypromellose, magnesium stearate, PEG, sodium benzoate, stearic acid, titanium dioxide. May also contain D&C yellow #10, FD&C yellow #5 (tartrazine), magnesium silicate, mineral oil, silica, sodium lauryl sulfate, starch, triacetin, wax.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


KEEP OUT OF REACH OF CHILDREN

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

855-60855-60

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
61919-855-602023-10-24C16284748780-1f386c64a-102d-0266-e053-dadaa90a7c1aSENNA PLUS
61919-855-602023-01-30C16284748780-1f386c64a-102d-0266-e053-dadaa90a7c1aSENNA PLUS

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61919-855-60EA - Each61919-8550d501e82-8289-4746-81b4-9caaa5d2b9e512019-08-06
61919-855-71EA - Each61919-85588d5fd20-6565-4221-832a-c64742630c4412019-08-06
57896-458-01EA - Each57896-45882a9f106-1f82-48a1-829f-694eff237f7712019-05-02
57896-458-06EA - Each57896-458574cdb7f-d2e3-4d74-bfbc-92ed90129f9012019-07-02
57896-458-10EA - Each57896-458d10542ed-cf8a-48a0-8e82-e9244b15208212019-07-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61919-85561919-855-60
57896-458

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Senna PlusSENNOSIDES AND DOCUSATE SODIUMGeri-Care Pharmaceutical Corp616a896a-d238-7f7c-e053-2a91aa0a0f5b2025-12-02WarningsExact identifier
ndc (product): 57896-458
07497460-3fd7-3d6a-e063-6294a90ad7218eec5f92-4f93-ea01-e053-2a95a90a3d392023-10-09WarningsExact identifier
spl set id: 8eec5f92-4f93-ea01-e053-2a95a90a3d39

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.